Simplicity Wealth LLC Trims Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Simplicity Wealth LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 65.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,243 shares of the healthcare conglomerate’s stock after selling 4,170 shares during the period. Simplicity Wealth LLC’s holdings in UnitedHealth Group were worth $1,134,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of UNH. SLT Holdings LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $3,459,000. AlphaQuest LLC grew its stake in UnitedHealth Group by 187.7% during the fourth quarter. AlphaQuest LLC now owns 676 shares of the healthcare conglomerate’s stock valued at $342,000 after acquiring an additional 441 shares in the last quarter. Miramar Capital LLC grew its stake in UnitedHealth Group by 0.9% during the fourth quarter. Miramar Capital LLC now owns 23,425 shares of the healthcare conglomerate’s stock valued at $11,850,000 after acquiring an additional 198 shares in the last quarter. Argentarii LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $1,887,000. Finally, OFI Invest Asset Management bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $62,838,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on UNH shares. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research report on Friday, January 10th. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Up 1.2 %

Shares of UnitedHealth Group stock opened at $493.35 on Monday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $513.78 and its two-hundred day simple moving average is $553.39. The company has a market cap of $451.28 billion, a P/E ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.83 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.70%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.